1. Home
  2. WAT vs CTRA Comparison

WAT vs CTRA Comparison

Compare WAT & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • CTRA
  • Stock Information
  • Founded
  • WAT 1958
  • CTRA 1989
  • Country
  • WAT United States
  • CTRA United States
  • Employees
  • WAT N/A
  • CTRA N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • CTRA Oil & Gas Production
  • Sector
  • WAT Industrials
  • CTRA Energy
  • Exchange
  • WAT Nasdaq
  • CTRA Nasdaq
  • Market Cap
  • WAT 17.4B
  • CTRA 18.0B
  • IPO Year
  • WAT 1995
  • CTRA 1990
  • Fundamental
  • Price
  • WAT $382.16
  • CTRA $26.34
  • Analyst Decision
  • WAT Buy
  • CTRA Buy
  • Analyst Count
  • WAT 13
  • CTRA 17
  • Target Price
  • WAT $379.00
  • CTRA $32.65
  • AVG Volume (30 Days)
  • WAT 652.9K
  • CTRA 9.4M
  • Earning Date
  • WAT 11-04-2025
  • CTRA 11-03-2025
  • Dividend Yield
  • WAT N/A
  • CTRA 3.34%
  • EPS Growth
  • WAT 3.82
  • CTRA 31.20
  • EPS
  • WAT 10.88
  • CTRA 2.17
  • Revenue
  • WAT $3,105,638,000.00
  • CTRA $6,666,000,000.00
  • Revenue This Year
  • WAT $7.12
  • CTRA $47.08
  • Revenue Next Year
  • WAT $6.22
  • CTRA $7.39
  • P/E Ratio
  • WAT $34.88
  • CTRA $12.16
  • Revenue Growth
  • WAT 6.90
  • CTRA 25.92
  • 52 Week Low
  • WAT $275.05
  • CTRA $22.33
  • 52 Week High
  • WAT $423.56
  • CTRA $29.95
  • Technical
  • Relative Strength Index (RSI)
  • WAT 69.65
  • CTRA 65.67
  • Support Level
  • WAT $340.09
  • CTRA $26.10
  • Resistance Level
  • WAT $391.79
  • CTRA $26.88
  • Average True Range (ATR)
  • WAT 10.91
  • CTRA 0.65
  • MACD
  • WAT 1.20
  • CTRA 0.18
  • Stochastic Oscillator
  • WAT 80.12
  • CTRA 86.02

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.

Share on Social Networks: